1. Wu, Yuanhua, Cai, Jing, Pang, Bo, He, Qiansong, Zhang, Anbang. . Bioinformatic Identification of Signaling Pathways and Hub Genes in Vascular Dementia. In Actas espanolas de psiquiatria, 52, 83-98. doi:10.62641/aep.v52i2.1601. https://pubmed.ncbi.nlm.nih.gov/38622006/
2. Du, Hongxia, Xiao, Guangxu, Xue, Zhifeng, Wang, Xiaoying, Zhu, Yan. 2021. QiShenYiQi ameliorates salt-induced hypertensive nephropathy by balancing ADRA1D and SIK1 expression in Dahl salt-sensitive rats. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 141, 111941. doi:10.1016/j.biopha.2021.111941. https://pubmed.ncbi.nlm.nih.gov/34328102/
3. Chen, Wei, Zhang, Taoyuan, Zhang, Hui. 2024. Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease. In Neuroscience letters, 832, 137816. doi:10.1016/j.neulet.2024.137816. https://pubmed.ncbi.nlm.nih.gov/38729598/
4. Kraboth, Zoltán, Kajtár, Bela, Gálik, Bence, Miseta, Attila, Kalman, Bernadette. 2021. Involvement of the Catecholamine Pathway in Glioblastoma Development. In Cells, 10, . doi:10.3390/cells10030549. https://pubmed.ncbi.nlm.nih.gov/33806345/
5. Shorter, Daryl I, Zhang, Xuefeng, Domingo, Coreen B, Kosten, Thomas R, Nielsen, David A. 2020. Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant. In The American journal of drug and alcohol abuse, 46, 184-193. doi:10.1080/00952990.2019.1674864. https://pubmed.ncbi.nlm.nih.gov/31914324/
6. Nonen, S, Okamoto, H, Fujio, Y, Kitabatake, A, Azuma, J. 2007. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy. In The pharmacogenomics journal, 8, 78-84. doi:. https://pubmed.ncbi.nlm.nih.gov/17404580/